Related Experiment Video
Updated: Aug 25, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Antibiotic resistance of Acinetobacter calcoaceticus strains isolated from patients treated in intensive care units
1Bacteriology Laboratory, Hajdú-Bihar County Institute National Public Health Service, Debrecen, Hungary.
Abstract:
The distribution according to specimens and susceptibility to antimicrobial agents of 481 Acinetobacter calcoaceticus strains isolated from patients treated in intensive care units were studied. They occurred most frequently in tracheal specimens and pus. Using disk diffusion test the strains proved to be multiple resistant to ampicillin (86.3%), azlocillin (86.7%), mezlocillin (84.0%), cefamandole (99.7%), cefoxitin (94.1%), cefuroxime (90.6%), cefoperazone (84.9%), cefotaxime (82.0%), ceftriaxone (81.0%), tobramycin (71.2%), gentamicin (86.2%), chloramphenicol (90.5%) and tetracycline (89.8%). Based on the lowest incidence of resistant strains imipenem (0%), netilmicin (2.6%), amikacin (4.9%), ampicillin+sulbactam (8.9%), amoxicillin+clavulanic acid (29.4%), pefloxacin (26.2%), ciprofloxacin (30.1%), ofloxacin (34.3%), cotrimoxazole (41.6%), carbenicillin (41.2%) or ceftazidime (55.4%) may be the drug of choice in nosocomial A. calcoaceticus infections.
Insights
Acinetobacter calcoaceticus strains from intensive care units show high resistance to many antibiotics. Imipenem and netilmicin are potential choices for treating these difficult nosocomial infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Acinetobacter calcoaceticus is a significant opportunistic pathogen, particularly in healthcare settings.
- Intensive care units (ICUs) are prone to infections caused by multidrug-resistant bacteria.
- Understanding antimicrobial susceptibility patterns is crucial for effective treatment of Acinetobacter infections.
Purpose of the Study:
- To determine the distribution of Acinetobacter calcoaceticus isolates from ICU patients.
- To evaluate the susceptibility of these isolates to a wide range of antimicrobial agents.
- To identify potential drugs of choice for treating nosocomial Acinetobacter calcoaceticus infections.
Main Methods:
- Isolation and identification of 481 Acinetobacter calcoaceticus strains from ICU patients.
- Analysis of specimen types where strains were most frequently found.
- Antimicrobial susceptibility testing using the disk diffusion method.
Main Results:
- Acinetobacter calcoaceticus was most prevalent in tracheal specimens and pus.
- High rates of multidrug resistance were observed, with over 80% resistance to ampicillin, azlocillin, mezlocillin, cefoxitin, cefuroxime, cefoperazone, cefotaxime, ceftriaxone, gentamicin, chloramphenicol, and tetracycline.
- Low resistance rates (<10%) were noted for imipenem, netilmicin, and amikacin, suggesting their potential efficacy.
Conclusions:
- Acinetobacter calcoaceticus strains in ICUs exhibit extensive resistance to commonly used antibiotics.
- Imipenem, netilmicin, and amikacin demonstrate promising activity against these resistant strains.
- These findings guide the selection of appropriate antimicrobial therapy for nosocomial Acinetobacter calcoaceticus infections.
More Related Videos
07:41Quantification, Viability Assessment, and Visualization Strategies for Acinetobacter Biofilms
Published on: August 4, 2023
05:06Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Related Concept Videos
Antibiotic Selection
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance